AMERICAN JOINT COMMITTEE ON CANCER

美国癌症联合委员会

• 批准号: 2085974
• 负责人: DAVID P WINCHESTER
• 金额: $ 5万
• 依托单位: AMERICAN COLLEGE OF SURGEONS
• 依托单位国家: 美国
• 财政年份: 1980
• 资助国家: 美国
• 起止时间: 1980-03-01 至 1995-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2085974
• 关键词: Kaposi's sarcoma; biomarker; brain neoplasms; cancer information system; data collection; female reproductive system neoplasm; information dissemination; intestine neoplasm; liver neoplasms; mesothelioma; metastasis; neoplasm /cancer classification /staging; prognosis; publications

The American Joint Committee on Cancer (AJCC) has been engaged in a clinical research project to develop staging classifications for cancers of all anatomic sites. Imminent directives for the AJCC derive from its past accomplishments of publication of three editions of the Manual for Staging Cancer. A new governance for the AJCC is stability in staging. Planned future activities of the AJCC include: 1. Refine present recommendations through comparisons with other established systems for staging and adjustments, where justified, to make compatible, i.e., pediatric tumors and gynecologic sites. 2. Identify variances and reaching accommodations between the staging systems of the AJCC and the International Union Against Cancer (UICC). Future publications of both organizations will reflect these reconciliations. 3. Continue studying the importance of molecular markers and prognostic indices and their role in staging. 4. Explore means and methods to encourage acceptance and use of the staging classifications and vigorously promote the value and use of the system in research protocols, medical schools, residency training programs, clinical practice, research, publications, and end-results reporting. 5. Investigate the need and feasibility of publishing articles on staging of cancer at specific sites or for certain physiologic systems, i.e., genitourinary and gynecologic, to accommodate the specialties of oncology practice and to encourage use of the staging classifications. 6. Develop staging schemes in accordance with national and international groups for the following sites: Kaposi's sarcoma, spinal cord, small intestine, mesotheliomas, fallopian tube, malignant carcinoid tumors, and tumors metastatic to the brain and liver. 7. Refine, publicize, distribute, and encourage the use of site- specific, cancer data collection forms.

美国癌症联合委员会（AJCC）一直致力于 发展癌症分期分类的临床研究计划 所有的解剖部位。对AJCC的紧迫指示来自其 过去出版三版《手册》的成就 癌症分期AJCC的新治理是分期的稳定性。 非洲犹太人联合会今后计划开展的活动包括： 1.通过与其他建议的比较完善现有建议 在合理的情况下，建立分期和调整制度， 使兼容，即，儿科肿瘤和妇科部位。 2.确定分段之间的差异并达成适应 AJCC和国际抗癌联盟（UICC）的系统。 这两个组织今后的出版物将反映这些情况。 和解。 3.继续研究分子标志物和预后的重要性 指数及其在分期中的作用。 4.探讨各种手段和方法，鼓励接受和使用 分期分类，大力推广的价值和使用 研究方案、医学院、住院医师培训系统 项目、临床实践、研究、出版物和最终结果 报告. 5.调查发表有关文章的必要性和可行性 特定部位或某些生理系统的癌症分期， 也就是说，生殖泌尿和妇科，以适应专业的 肿瘤学实践，并鼓励使用分期分类。 6.根据国家和国际标准制定分阶段计划， 组用于以下部位：卡波西肉瘤，脊髓，小 肠，间皮瘤，输卵管，恶性类癌肿瘤， 以及转移到大脑和肝脏的肿瘤。 7.完善、宣传、分发和鼓励使用网站- 具体的癌症数据收集表格。

项目成果

Clinical staging system for cancer of the salivary gland: a retrospective study.

唾液腺癌的临床分期系统：回顾性研究。

• DOI: 10.1002/1097-0142(19810601)47:11<2712::aid-cncr2820471130>3.0.co;2-a
• 发表时间: 1981
• 期刊: Cancer
• 影响因子: 6.2
• 作者: Levitt,SH;McHugh,RB;Gómez-Marin,O;Hyams,VJ;Soule,EH;Strong,EW;Sellers,AH;Woods,JE;Guillamondegui,OM
• 通讯作者: Guillamondegui,OM